Corticosteroid administration and treatment failure in acute exacerbation of chronic obstructive pulmonary disease

JAMA

Volumn 304, Issue 14, 2010, Pages 1554-

  Chang, Kwok Chiu ^a   Leung, Chi Chiu ^a   Kong, Fuk Yip ^b  

^a DEPARTMENT OF HEALTH   (Hong Kong)

^b HOSPITAL AUTHORITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG TREATMENT FAILURE; HOSPITAL READMISSION; HUMAN; LETTER; LUNG VENTILATION; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; NOTE; ORAL DRUG ADMINISTRATION; REPRODUCIBILITY; RETROSPECTIVE STUDY; SAMPLE SIZE; STATISTICAL ANALYSIS; TREATMENT FAILURE;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; DATA INTERPRETATION, STATISTICAL; HOSPITAL MORTALITY; HUMANS; INFUSIONS, INTRAVENOUS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SAMPLE SIZE; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE;

EID: 77957915937     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.1438     Document Type: Letter

References (4)

1. Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, Rothberg MB. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA. 2010;303(23):2359-2367.
2. Krishnan JA, Mularski RA. Acting on comparative effectiveness research in COPD. JAMA. 2010;303(23):2409-2410.
3. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ; CONSORT Group. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA. 2006;295(10):1152-1160. (Pubitemid 43352345)
4. Global strategy for the diagnosis, management, and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease Web site. http://www.goldcopd.org. Accessed July 12, 2010.